We’re back with Dr. Monica Gandhi and our own Jim Weiss! We’ve loved checking in with these two about the current state of COVID-19, and this time, they delivered an uplifting assessment and a ton of recent data and studies to back it up.
Last week, Elon Musk bought Twitter, plunging the platform and our role in it into an uncertain future. At the highest level, what could this mean for health care communicators, practitioners, and patients looking for information? We sat down with our own social media experts, Chuck Hemann, Anke Knospe, and Jurgen Castro to hear their expert opinions.
We’re diving into a new topic on the podcast: menstrual health. Lauren Wang, Founder and CEO of The Flex Company, discusses how her company innovates in health care and makes periods a more normal and empathetic topic in everyday life. Plus, she shares her expert advice for female entrepreneurs pitching to a room full of men.
Our CEO, Shankar Narayanan, joins us for this week’s show. He opens up about why he joined Real Chemistry and shares where the industry and our organization are headed. Plus, he shares his ideal mixtape that will definitely give you earbud envy.
Check out the first episode of the year with Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research, FDA, and Jim Weiss, our Founder, and Chairman! Learn about how the US is evolving to living with an endemic, the role of communications for the FDA, and what's in store for the next generation of therapies.
As we head into the holiday season, there are a lot of questions and concerns about the Omicron variant. Dr. Monica Gandhi, Professor of Medicine at UCSF, joins the show to unpack the nuances of Omicron and share why she's optimistic about where we are in the pandemic.
The year's final episode is here, and we saved the best for last! Dr. Scott Gottlieb, former FDA Commissioner, chats with Jim Weiss, our Founder & Chairman, about lessons learned from COVID-19, how variants will impact our future (i.e., JP Morgan 2022), and how we can prepare for the next pandemic.
It's a family affair on this week's episode of the show! Our Global Head of Facilities, Beth Weiss, and Jim Weiss, our Founder, and CEO, join the show to chat about Beth's coming out journey and the importance of living as your authentic self.
Curious about the basics of market access and value? Amy Grogg, PharmD, one of our CEO Advisory Board Members, joins the show to unpack all things market access and value. Plus, she dives into her appreciation of Green Day.
If Sung Poblete had one wish, it would be to put her company out of business because cancer as we know it is no more. The President & CEO of Stand Up to Cancer joins the show to discuss the mission of making every cancer patient a long-term survivor and shares her admiration of Rufus Wainwright.
This week's guest is a true changemaker and force for good in healthcare. Maimah Karmo, President & CEO of the Tigerlily Foundation joins the show to discuss how she's advocating and driving actionable solutions in our industry. Plus, she shares her love of Michael Jackson’s Thriller album.
She’s back! Mary Stutts, Chief Global Inclusion & Health Equity Officer of Real Chemistry, joins the show again to discuss how to integrate health equity into everything you do.
Health data is medicine, according to Ardy Arianpour, CEO & Co-Founder of Seqster. Ardy is joined by Real Chemistry’s Larry Mickelberg to discuss how we can break down health data silos and what that would mean for the future of healthcare.
Co-Creator of TEDMED and Founder & Co-Host, LIFE ITSELF, with Dr. Sanjay Gupta, Marc Hodosh, joins the show to discuss his upcoming health conference and the genesis of TEDMED. Plus, he shares why he'd bring a CD with him on a deserted island.
We can’t undo 400 years of systemic racism in a week, creating equitable healthcare takes a movement not a moment. André Blackman, Founder & CEO of Onboard Health & Abby Hayes, Practice Leader of DE&I Engagement, Real Chemistry join this week’s episode to discuss designing an equitable healthcare system.
It is an honor to have Sandra Lindsay, a critical care nurse, and the first person in the US to receive the COVID-19 vaccine join our show. As a healthcare hero, she opens up about her frontline experience and the importance of vaccinations, plus she discusses her appreciation of Bob Marley.
Doubling the survival rate of pancreatic cancer is an ambitious goal but a noble one. Julie Fleshman joins the show to discuss how her organization, PanCAN, is ensuring a world in which all pancreatic cancer patients will thrive.
Host of The Breast Talk Ever podcast, Breast Cancer survivor, and committed change driver, La Tonya Davis joins this week’s show to share her truly inspiring story.
Dr. Omolola Salako, 5th Annual Grand Prize winner of the Astellas Oncology C3 Prize, joins the podcast to discuss her experience as an oncologist turned innovator and founder of a digital health tech startup. Learn about how she is working to empower patients in her home country of Nigeria.
Healthcare is forever changed because of COVID-19. Terri Sanders of HIMSS and our Founder & CEO, Jim Weiss, share what innovations from the pandemic can shape the future of health.
The use of digital tools is not the same as digital transformation, so what does this mean for healthcare? Dr. Michael Blum, Chief Digital Transformation Officer of UCSF Health, joins the show to discuss the digital health renaissance, the progress needed for our industry, plus he shares a pretty clever answer for the album he'd bring on a desert island.
Real Chemistry Founder & CEO, Jim Weiss & Hugh Forrest, Chief Programming Officer of SXSW, discuss the innovative, future-thinking nature of SXSW, the excitement around #RealChemSXSW, and reminisce on the early days of the festival.
Telling stories of how information and tech can transform healthcare is essential for the entire ecosystem. Karen Groppe, Senior Director of Strategic Communications at HIMSS joins the show to discuss this, the importance of the whole message, and her love of Earth, Wind & Fire.
W2O recently acquired Swoop and IPM.ai to better equip our clients with tech-enabled solutions. This week, IPM.ai's Jonathan and W2O's Mary Claire Duch discuss our new partnership and the role tech-enablement plays in healthcare.